US 11339198
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
granted A61PA61P35/00A61P37/02
Quick answer
US patent 11339198 (Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P35/00, A61P37/02